PRQR

NASD ProQR Therapeutics N.V.
Oct 12, 2026 · 6:27 PM ET LAST TRADE Market Closed

$1.68 ↑ +0.06 (+3.70%) Trading Up from the previous close of $1.62, $0.02 below the day’s high of $1.70

YTD change
-16.83%
vs 20-day SMA
-2.54%
vs 200-day SMA
-3.23%

Price ranges

Previous day
$1.56 $1.63
open $1.57 close $1.63
+$0.06 (+3.82%)
Today
$1.56 $1.70
open $1.62 now $1.68
+$0.06 (+3.70%)
Past week
$1.54 $1.71
from $1.64 now $1.68
+$0.04 (+2.75%)
Past month
$1.54 $1.92
from $1.86 now $1.68
-$0.18 (-9.68%)
This year
$1.33 $2.46
from $2.02 now $1.68
-$0.34 (-16.83%)

Price & Performance

-0.17 (-9.44%) / 6M

$1.33$1.72$2.12$2.51Apr 13Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 93.0% away from all-time highs of $24.00
  • PRQR is down 17% since the beginning of the year
  • PRQR is down 30% over the past 12 months
  • PRQR is down 10% over the past 1 month
  • 2% of all PRQR investors are betting against PRQR

PRQR reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -28.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.092356
Earnings momentum +18.3% Quarterly EPS growth
Quarterly change +18.3%

Valuation

P/E ratio N/A
Enterprise value $60.4M
Beta 1.54

Balance sheet & scale

IncomeN/A
Revenue$21.1M
Cash$133.9M
Debt$15.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $240.2M

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,179.27 +0.83%
JNJ Johnson & Johnson $261.44 +1.93%
ABBV AbbVie, Inc. $276.47 +1.49%
MRK Merck & Co., Inc. $145.60 +2.26%
RHHVF Roche Holding Ltd $434.14 +1.96%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.